Skip to main content
Clinical Trials/NCT06229951
NCT06229951CompletedNot Applicable

Efficacy of Hydrolyzed Collagen and Undenatured Collagen Type II in Alleviating Pain in Patients With Knee Osteoarthritis

Prince of Songkla University1 site in 1 country68 target enrollmentStarted: November 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
68
Locations
1
Primary Endpoint
Pain (VNRS)

Study Overview

Brief Summary

Randomized controlled trial

Targeted patients who come to receive treatment for osteoarthritis that meets the research indications will be assigned to a random group by the box of 4 randomization method, with a sequence that is randomly generated by a computer. The groups are divided into two groups:

Group 1: Patients who have taken 480 mg of hydrolyzed collagen and 20 mg of undenatured type II collagen

Group 2: Control patients will take placebo

Primary outcome : Pain level

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
50 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age: 50-80 years old
  • •Medial compartment knee osteoarthritis
  • •Kellgren and Lawrence classification stage 2 -3
  • •Able to walk without walking aid

Exclusion Criteria

  • •History of knee surgery on the study side
  • •History of intra-articular steroid injection within 6 months prior to study entry
  • •Systemic arthritis conditions
  • •Degenerative neurological and muscular conditions in the lower extremities
  • •Chronic kidney disease with CrCl < 30 ml/min (glomerular filtration rate <60 mL/min/1.73 m2)

Arms & Interventions

Control group

Placebo Comparator

Control patients will take placebo 2 tabs a day

Intervention: Placebo (Other)

Collagen supplement group

Experimental

Patients who have taken 480 mg of hydrolyzed collagen and 20 mg of undenatured type II collagen (in one tablet) 2 tabs a day

Intervention: Collagen (Dietary Supplement)

Outcomes

Primary Outcomes

Pain (VNRS)

Time Frame: 12 weeks

Pain level (verbal numerical rating scale :VNRS) - 0 is no pain and 10 is the worst pain

Secondary Outcomes

  • Rescue medication(12 weeks)
  • Knee and Osteoarthritis Outcome Score (KOOS)(12 weeks)
  • Patient satisfaction(12 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Varah Yuenyongviwat

Professor

Prince of Songkla University

Study Sites (1)

Loading locations...

Similar Trials

Hydrolyzed Collagen and Undenatured... | Clinical Trial